Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Postdiagnosis physical activity and dietary inflammatory and insulinemic potential with overall survival in men with nonmetastatic prostate cancer
Indexado
WoS WOS:001497664300001
Scopus SCOPUS_ID:105006810262
DOI 10.1007/S10654-025-01240-X
Año 2025
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Inflammation and insulin resistance are associated with increased mortality in the general population. However, it remains unclear how physical activity and proinflammatory/hyperinsulinemic diets influence overall survival in prostate cancer patients. We analyzed 4779 men with nonmetastatic prostate cancer from the Health Professionals Follow-up Study. Postdiagnosis physical activity and diet were assessed using validated self-reported questionnaires. We used the validated dietary scores to empirically assess the anti-inflammatory (rEDIP) and anti-insulinemic (rEDIH) potential of dietary patterns based upon specific combinations of food groups. Cox regression model was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). During a median of 15 years of follow-up, we identified 2282 deaths. Compared to men with < 3 MET-h/week of postdiagnosis physical activity, multivariable-adjusted HRs (95% CI) were 0.80 (0.68-0.95) for 9-< 24 MET-h/week, 0.63 (0.53-0.75) for 24-< 48 MET-hours/week and 0.61 (0.51-0.73) for >= 48 MET-hours/week in relation to all-cause mortality (P-trend < 0.001). Both vigorous and non-vigorous activities after diagnosis were associated with lower all-cause mortality (P-trend < 0.001). Moreover, post-diagnosis rEDIP and rEDIH scores were inversely associated with all-cause mortality (HR per 1-SD increase: 0.93 (0.89-0.99) for rEDIP; 0.91 (0.86-0.96) for rEDIH). In joint analyses, men with high physical activity and high rEDIP (or rEDIH) score showed approximately 30-36% lower risks of all-cause mortality, compared to those with low physical activity and low diet scores. In conclusion, high physical activity and low proinflammatory and hyperinsulinemic diets were independently associated with decreased risk of all-cause mortality in men with prostate cancer. Men with both high physical activity and low proinflammatory and hyperinsulinemic diets after diagnosis have the lowest mortality rate.

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Public, Environmental & Occupational Health
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Lee, Dong Hoon - Yonsei Univ - Corea del Sur
Harvard TH Chan Sch Publ Hlth - Estados Unidos
Yonsei University - Corea del Sur
Harvard T.H. Chan School of Public Health - Estados Unidos
2 Rezende, L. F. M. Hombre Univ Fed Sao Paulo - Brasil
Universidad Autónoma de Chile - Chile
Universidade Federal de São Paulo - Brasil
3 Ferrari, Gerson - Universidad de Santiago de Chile - Chile
4 Zhang, Yiwen - Harvard TH Chan Sch Publ Hlth - Estados Unidos
Harvard T.H. Chan School of Public Health - Estados Unidos
5 Wang, Qiao-Li - Harvard Univ - Estados Unidos
Harvard Medical School - Estados Unidos
6 Oh, Hannah - Korea Univ - Corea del Sur
Korea University - Corea del Sur
7 Keum, NaNa Mujer Harvard TH Chan Sch Publ Hlth - Estados Unidos
Dongguk Univ - Corea del Sur
Harvard T.H. Chan School of Public Health - Estados Unidos
Dongguk University, Gyeongju - Corea del Sur
8 Hu, Jinbo - Harvard TH Chan Sch Publ Hlth - Estados Unidos
Chongqing Med Univ - China
Harvard T.H. Chan School of Public Health - Estados Unidos
The First Affiliated Hospital of Chongqing Medical University - China
9 Jeon, Justin Y. Hombre Yonsei Univ - Corea del Sur
Yonsei University - Corea del Sur
10 Mucci, Lorelei A. - Harvard TH Chan Sch Publ Hlth - Estados Unidos
Harvard T.H. Chan School of Public Health - Estados Unidos
11 Giovannucci, Edward L. Hombre Harvard TH Chan Sch Publ Hlth - Estados Unidos
Harvard T.H. Chan School of Public Health - Estados Unidos

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
CNPq
National Council for Scientific and Technological Development
NIH
American Cancer Society
National Cancer Institute
NCI
Yonsei University
Arkansas, California, Colorado
Centers for Disease Control and Prevention's National Program of Cancer Registries (NPCR)
National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital as home of the Health Professionals Follow-up Study

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
The authors would like to acknowledge the contribution to this study from central cancer registries supported through the Centers for Disease Control and Prevention's National Program of Cancer Registries (NPCR) and/or the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program. Central registries may also be supported by state agencies, universities, and cancer centers. Participating central cancer registries include the following: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Indiana, Iowa, Kentucky, Louisiana, Massachusetts, Maine, Maryland, Michigan, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, Seattle SEER Registry, South Carolina, Tennessee, Texas, Utah, Virginia, West Virginia, Wyoming. We thank the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital as home of the Health Professionals Follow-up Study.
The authors would like to acknowledge the contribution to this study from central cancer registries supported through the Centers for Disease Control and Prevention\u2019s National Program of Cancer Registries (NPCR) and/or the National Cancer Institute\u2019s Surveillance, Epidemiology, and End Results (SEER) Program. Central registries may also be supported by state agencies, universities, and cancer centers. Participating central cancer registries include the following: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Indiana, Iowa, Kentucky, Louisiana, Massachusetts, Maine, Maryland, Michigan, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, Seattle SEER Registry, South Carolina, Tennessee, Texas, Utah, Virginia, West Virginia, Wyoming. We thank the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital as home of the Health Professionals Follow-up Study.
This work was supported by the NCI of the NIH under award numbers U01 CA167552 and R03 CA249027. E.L.G. is funded as an American Cancer Society Clinical Research Professor (grant CRP-23-1014041). D.H.L. is supported by the Yonsei University Research Fund of 2024-22-0093. L.F.M.R is supported by the National Council for Scientific and Technological Development\u2014CNPq (311109/2023-3).

Muestra la fuente de financiamiento declarada en la publicación.